Back to top
more

Bausch Health (BHC)

(Delayed Data from NYSE)

$8.53 USD

8.53
3,432,592

+0.17 (2.03%)

Updated Jul 1, 2022 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.75%
2Buy18.15%
3Hold9.70%
4Sell5.35%
5Strong Sell2.45%
S&P50010.91%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 41% (146 out of 251)

Industry: Medical - Generic Drugs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Balance Sheet

Research for BHC

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Bausch Health Cos Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017
Assets          
Cash & Equivalents 2,119 1,816 3,244 723 797
Receivables 1,775 1,577 1,839 1,865 2,130
Notes Receivable 0 0 0 0 0
Inventories 993 1,094 1,107 934 1,048
Other Current Assets 720 855 779 689 771
Total Current Assets 5,607 5,342 6,969 4,211 4,746
Net Property & Equipment 1,598 1,567 1,466 1,353 1,403
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 2,252 2,137 1,690 1,676 433
Intangibles 19,405 21,489 23,327 25,143 30,804
Deposits & Other Assets 340 664 411 109 111
Total Assets 29,202 31,199 33,863 32,492 37,497
Liabilities & Shareholders Equity 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017
Notes Payable 0 0 0 0 0
Accounts Payable 407 337 503 411 365
Current Portion Long-Term Debt 0 0 1,234 228 209
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 4,791 4,576 4,511 3,197 3,694
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 5,198 4,913 6,248 3,836 4,268
Mortgages 0 0 0 0 0
Deferred Taxes/Income 529 528 705 885 1,180
Convertible Debt 0 0 0 0 0
Long-Term Debt 22,654 23,925 24,661 24,077 25,235
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 855 1,228 1,113 879 870
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 29,236 30,594 32,727 29,677 31,553
Shareholders Equity 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017
Preferred Stock 0 0 0 0 0
Common Stock (Par) 10,317 10,227 10,172 10,121 10,090
Capital Surplus 462 454 429 413 380
Retained Earnings -8,961 -8,013 -7,452 -5,664 -2,725
Other Equity -1,852 -2,063 -2,013 -2,055 -1,801
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity -34 605 1,136 2,815 5,944
Total Liabilities & Shareholder's Equity 29,202 31,199 33,863 32,492 37,497
Total Common Equity -34 605 1,136 2,815 5,944
Shares Outstanding 359.40 355.40 352.50 349.70 348.50
Book Value Per Share -0.09 1.70 3.22 8.05 17.06

Fiscal Year End for Bausch Health Cos Inc falls in the month of December.

All items in Millions except Per Share data.

6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021
Assets          
Cash & Equivalents 2,460 2,119 1,904 1,856 1,893
Receivables 1,566 1,775 1,730 1,609 1,499
Notes Receivable 0 0 0 0 0
Inventories 1,045 993 1,058 1,086 1,076
Other Current Assets 765 720 632 899 924
Total Current Assets 5,836 5,607 5,324 5,450 5,392
Net Property & Equipment 1,579 1,598 1,584 1,590 1,556
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 2,282 2,252 2,266 2,255 2,150
Intangibles 19,059 19,405 19,735 20,151 20,482
Deposits & Other Assets 334 340 343 596 617
Total Assets 29,090 29,202 29,252 30,042 30,197
Liabilities & Shareholders Equity 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021
Notes Payable 0 0 0 0 0
Accounts Payable 471 407 455 442 342
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 4,303 4,791 4,982 5,075 4,556
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 4,774 5,198 5,437 5,517 4,898
Mortgages 0 0 0 0 0
Deferred Taxes/Income 552 529 513 516 520
Convertible Debt 0 0 0 0 0
Long-Term Debt 23,168 22,654 22,358 23,439 23,738
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 737 1,079 1,181 1,165
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 29,231 29,236 29,387 30,653 30,321
Shareholders Equity 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021
Preferred Stock 0 0 0 0 0
Common Stock (Par) 10,373 10,317 10,312 10,300 10,289
Capital Surplus 415 462 437 413 393
Retained Earnings -9,030 -8,961 -9,030 -9,218 -8,623
Other Equity -1,899 -1,852 -1,854 -2,106 -2,183
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity -141 -34 -135 -611 -124
Total Liabilities & Shareholder's Equity 29,090 29,202 29,252 30,042 30,197
Total Common Equity -141 -34 -135 -611 -124
Shares Outstanding 360.90 359.40 358.80 358.80 358.40
Book Value Per Share -0.39 -0.09 -0.38 -1.70 -0.35